Graphical Abstract from Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity

2026 Open access

Read full text

Authors: Chakrapani Tripathi, Sergey N. Zolov, John Nguyen, Frank Luh, Venkatesh Natarajan, Yun Yen

DOI: 10.1158/2767-9764.31645579

Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Chronic Lymphocytic Leukemia Research T-cell and B-cell Immunology